
Co-treatment with the anti-malarial drugs mefloquine and primaquine highly sensitizes drug-resistant cancer cells by increasing P-gp inhibition
Keywords: VIN; vinblasitne; ATO; atovaquone; CHL; chloroquine; PRL; primaquine; MEF; mefloquine; ART; artesunate; DOY; doxycycline; VER; verapamil; P-gp; p-glycoprotein; DMSO; dimethylsulfoxide; C-PARP; cleaved ploy ADP ribose polymerase; FACS; fluorescence-activat